BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CITI Program - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CITI Program
X-ORIGINAL-URL:https://about.citiprogram.org
X-WR-CALDESC:Events for CITI Program
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260714
DTEND;VALUE=DATE:20260717
DTSTAMP:20260604T133756Z
CREATED:20260604T133756Z
LAST-MODIFIED:20260604T133756Z
UID:62176-1783987200-1784246399@about.citiprogram.org
SUMMARY:Rapid Drug Analysis and Research (RaDAR) In-Person Meeting
DESCRIPTION:Join the National Institute of Standards and Technology (NIST) for a multi-day workshop\, bringing together scientists and public health professionals to discuss the Rapid Drug Analysis and Research (RaDAR) program. The event is designed as a collaborative forum to share updates on current and future program initiatives\, while supporting dialogue on drug analysis efforts across the public health community. \nThe workshop will focus on knowledge exchange and program development through: \n\nEducational sessions on RaDAR program initiatives and priorities\nDiscussions on best practices and lessons learned among current and prospective participants\nOpportunities for attendees to provide feedback to NIST on evolving drug analysis needs\n\nVisit the event page for more information.
URL:https://about.citiprogram.org/event/rapid-drug-analysis-and-research-radar-in-person-meeting/
LOCATION:Courtyard by Marriott Gaithersburg Washingtonian Center\, 204 Boardwalk Place\, Gaithersburg\, MD\, 20878\, United States
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/09/nist-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260714T130000
DTEND;TZID=America/New_York:20260714T140000
DTSTAMP:20260624T171441Z
CREATED:20260624T171321Z
LAST-MODIFIED:20260624T171441Z
UID:62383-1784034000-1784037600@about.citiprogram.org
SUMMARY:ClinicalTrials.gov: Essentials for Academic Medical Centers
DESCRIPTION:Join the FDA for a virtual training that provides guidance for staff at academic medical centers on meeting federal requirements for clinical trial registration and results reporting on ClinicalTrials.gov. Experts from multiple U.S. Food and Drug Administration (FDA) centers\, including CDER\, CDRH\, OCLP\, and CBER\, as well as the National Library of Medicine (NLM) within the National Institutes of Health (NIH)\, will address frequently asked questions related to regulatory obligations and the ClinicalTrials.gov Protocol Registration and Results System (PRS). \nThe training consists of a self-paced\, pre-recorded module followed by optional live panel sessions that expand on key concepts and allow participants to engage directly with subject matter experts. Attendees are encouraged to submit questions in advance to help guide discussion during the panels. \nKey components include: \n\nA required on-demand video covering foundational topics and regulatory expectations\nLive virtual panel sessions focused on practical applications and participant questions\nOpportunities to gain clarity on when and how to register studies and report results\n\nIntended Audience: \n\nAcademic Medical Centers\nClinicalTrials.gov administrators\nOffice of Clinical Research\nAcademic researchers\nSponsor-investigators\nPrincipal investigators\n\nTopics Covered: \n\nClinicalTrials.gov Registration and Results Reporting Requirements\nCommon Compliance Pitfalls and Corrective Actions\nCenter-Specific Guidance from CDER\, CBER\, and CDRH\nFeatures of the Protocol Registration and Results System (PRS)\nExpert Tips for Protocol Registration and Results Submission\nAvailable Tools and Resources\n\nBy completing both portions of the training\, participants will gain a clearer understanding of ClinicalTrials.gov requirements and approaches for accurately and timely sharing clinical trial information with the public. \nVisit the event page for more information.
URL:https://about.citiprogram.org/event/clinicaltrials-gov-essentials-for-academic-medical-centers/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2025/04/fda-logo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260714T140000
DTEND;TZID=America/New_York:20260714T150000
DTSTAMP:20260701T175335Z
CREATED:20260701T174450Z
LAST-MODIFIED:20260701T175335Z
UID:62537-1784037600-1784041200@about.citiprogram.org
SUMMARY:NSF SECURE SPARK Webinar: BIOSECURE Act and Beyond – Evolving Federal Biotech Policy
DESCRIPTION:The NSF SECURE SPARK Webinar\, “BIOSECURE Act and Beyond – Evolving Federal Biotech Policy\,” will examine the BIOSECURE Act\, enacted in December 2025 as Section 851 of the Fiscal Year 2026 National Defense Authorization Act (NDAA)\, and its potential impact on research institutions. The legislation reflects bipartisan concerns regarding national security risks associated with certain foreign biotechnology companies\, including issues related to the handling of sensitive biological data such as genetic and proteomic information. While full enforcement is expected to begin in approximately two years\, organizations involved in research may benefit from understanding the law’s requirements and considering potential operational impacts in advance. \nParticipants will also learn about the mechanisms through which entities may be designated as “biotechnology companies of concern\,” including designation through the Department of Defense’s annually updated Section 1260H list. The webinar will review recent updates to that list\, including the addition of biotechnology companies WuXi AppTec\, Complete Genomics\, and Novogene\, and will explore related recommendations from the National Security Commission on Emerging Biotechnology and ongoing legislative developments in this area. \nVisit the event page for more information.
URL:https://about.citiprogram.org/event/nsf-secure-spark-webinar-biosecure-act-and-beyond-evolving-federal-biotech-policy/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://about.citiprogram.org/wp-content/uploads/2024/02/mid-career-advancement.png
END:VEVENT
END:VCALENDAR